Research
Listed products: an arsenal of opportunity
Things have moved quickly in listed products, making it easier than ever for advisers to build bespoke, well-diversified portfolios for clients, Dominic McCormick writes.
Research
Research
Advisers are over-diversifying: panel
Michael Furey thinks managers spreading risk across a glut of funds is folly. Look for more idiosyncratic risk factors, he says, if you want real alpha.
